Sat.Aug 14, 2021

article thumbnail

New patent for Boehringer Ingelheim drug GLYXAMBI

Drug Patent Watch

Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eleven patents…. The post New patent for Boehringer Ingelheim drug GLYXAMBI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98
article thumbnail

Metabolism changes with age, just not when you might think

Scienmag

Researchers have precisely measured life’s metabolic highs and lows, from birth to old age, and the findings might surprise you DURHAM, N.C. — Most of us remember a time when we could eat anything we wanted and not gain weight. But a new study suggests your metabolism — the rate at which you burn calories […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent for Bayer Hlthcare drug ASTEPRO ALLERGY

Drug Patent Watch

Annual Drug Patent Expirations for ASTEPRO+ALLERGY Astepro Allergy is a drug marketed by Bayer Hlthcare and is included in one NDA. The generic ingredient in ASTEPRO ALLERGY is azelastine hydrochloride.…. The post New patent for Bayer Hlthcare drug ASTEPRO ALLERGY appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

‘Likes’ and ‘shares’ teach people to express more outrage online

Scienmag

Social media platforms like Twitter amplify expressions of moral outrage over time because users learn such language gets rewarded with an increased number of “likes” and “shares,” a new Yale University study shows. And these rewards had the greatest influence on users connected with politically moderate networks. “Social media’s incentives are changing the tone of […].

52
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

New patent for Bayer Hlthcare drug CHILDREN’S ASTEPRO ALLERGY

Drug Patent Watch

Annual Drug Patent Expirations for CHILDREN%27S+ASTEPRO+ALLERGY For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com. The post New patent for Bayer Hlthcare drug CHILDREN’S ASTEPRO ALLERGY appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Study takes unprecedented peek into life of 17,000-year-old mammoth

Scienmag

An international research team has retraced the astonishing lifetime journey of an Arctic woolly mammoth, which covered enough of the Alaska landscape during its 28 years to almost circle the Earth twice. Scientists gathered unprecedented details of its life through analysis of a 17,000-year-old fossil from the University of Alaska Museum of the North. […].

More Trending

article thumbnail

NASA at your table: Where food meets methane

Scienmag

Today, human sources are responsible for 60% of global methane emissions, coming primarily from the burning of fossil fuels, decomposition in landfills and the agriculture sector. Nearly a quarter of methane emissions can be attributed to agriculture, much of which is from raising livestock. Rice cultivation and food waste are also important sources of agricultural […].

52
article thumbnail

New patent for Abbvie Inc drug MAVYRET

Drug Patent Watch

Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…. The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

How Contract CRAs Should Negotiate and Keep Their Enthusiasm During Their Clinical Research Careers

Clinical Trial Gurus

Contract Clinical Research Associates can obtain numerous contracts throughout their career. The art of negotiation, persuasion, as well as mastering motivational techniques would come in handy throughout one’s CRA career.

article thumbnail

Informa Connect’s Coupon & Copay

Drug Channels

Informa Connect’s Coupon & Copay. Hybrid Event | October 13-20 In-Person: October 13-14 in Philadelphia, PA Virtual: October 19-20 www.informaconnect.com/couponcopay. It’s time to get the gang back together! With an improving landscape, Informa Connect is pleased to announce that Coupon and Copay will return this Fall as a hybrid event, in-person October 13-14 in Philadelphia, PA and virtually October 19-20.

Drugs 40
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Filling pharmaceutical powders efficiently and safely

Syntegon Technology Pharma Blog

52
article thumbnail

Which drugs have the most supplementary protection certificates?

Drug Patent Watch

This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…. The post Which drugs have the most supplementary protection certificates? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52